In the general population, several clinical studies (e.g., AMORIS (Apolipoprotein-related MOrtality RISk) [38] or INTERHEART [39]) have shown that the ApoB/ApoA-I ratio is strongly correlated with cardiovascular events such as myocardial infarction and stroke [40]. The gene discussed is APOA1; the disease is myocardial infarction.